0001859506-21-000001.txt : 20210429 0001859506-21-000001.hdr.sgml : 20210429 20210429065959 ACCESSION NUMBER: 0001859506-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210429 DATE AS OF CHANGE: 20210429 EFFECTIVENESS DATE: 20210429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bilayer Therapeutics, Inc. CENTRAL INDEX KEY: 0001859506 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-397597 FILM NUMBER: 21866995 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 734-358-9015 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001859506 Bilayer Therapeutics, Inc. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 734-358-9015 DELAWARE None None Corporation true 2020 Thomas A. Collet 14th Floor, One Broadway Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Robert Langer 14th Floor, One Broadway Cambridge MA MASSACHUSETTS 02142 Director Joshua Korzenik 14th Floor, One Broadway Cambridge MA MASSACHUSETTS 02142 Director Carlo Traverso Giovanni 14th Floor, One Broadway Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2021-04-19 false true false 0 3600000 2000000 1600000 false 2 0 0 0 false Bilayer Therapeutics, Inc. /s/ Thomas A. Collet Thomas A. Collet President 2021-04-28